$480 Million is the total value of Tamarack Advisers, LP's 46 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 97.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| PCRX | Buy | PACIRA BIOSCIENCES INCequity | $43,593,000 | +10.7% | 735,000 | +12.2% | 9.08% | -25.2% |
| MDT | Buy | MEDTRONIC PLCequity | $43,290,000 | +66.6% | 375,000 | +50.0% | 9.02% | +12.7% |
| UTHR | Buy | UNITED THERAPEUTICS CORPequity | $28,114,000 | +74.0% | 183,000 | +14.4% | 5.86% | +17.6% |
| RIGL | Sell | RIGEL PHARMACEUTICALS INCequity | $25,963,000 | +44.2% | 7,450,000 | -0.7% | 5.41% | -2.5% |
| NUAN | Buy | NUANCE COMMUNICATIONS INCequity | $25,001,000 | +115.2% | 575,000 | +64.3% | 5.21% | +45.5% |
| MDRX | Sell | ALLSCRIPTS HEALTHCARE SOLUTIequity | $21,593,000 | +39.6% | 1,500,000 | -21.1% | 4.50% | -5.6% |
| LH | Buy | LABORATORY CRP OF AMER HLDGSequity | $20,392,000 | +35.4% | 100,000 | +25.0% | 4.25% | -8.5% |
| HOLX | Sell | HOLOGIC INCequity | $19,987,000 | +0.2% | 275,000 | -8.3% | 4.16% | -32.2% |
| DGX | Buy | QUEST DIAGNOSTICS INCequity | $19,841,000 | +73.3% | 165,000 | +65.0% | 4.13% | +17.2% |
| ATRC | Buy | ATRICURE INCequity | $19,632,000 | +40.6% | 366,400 | +4.7% | 4.09% | -5.0% |
| PRGO | Sell | PERRIGO CO PLCequity | $16,631,000 | -15.8% | 375,000 | -12.8% | 3.46% | -43.0% |
| TPB | Buy | TURNING POINT BRANDS INCequity | $15,903,000 | +178.0% | 370,000 | +80.5% | 3.31% | +87.9% |
| ICUI | Buy | ICU MEDICAL INCequity | $15,452,000 | +38.6% | 73,000 | +19.7% | 3.22% | -6.3% |
| LNTH | LANTHEUS HOLDINGS INCequity | $13,039,000 | +8.3% | 950,000 | 0.0% | 2.72% | -26.8% | |
| RDNT | Buy | RADNET INCequity | $12,093,000 | +26.0% | 650,000 | +4.0% | 2.52% | -14.8% |
| SIBN | Buy | SI-BONE INCequity | $11,250,000 | +93.6% | 385,000 | +57.1% | 2.34% | +30.9% |
| SNRHU | New | SENIOR CONNECT ACQUISITION Cequity unit | $9,837,000 | – | 950,000 | +100.0% | 2.05% | – |
| VRTX | New | VERTEX PHARMACEUTICALS INCequity | $9,594,000 | – | 42,000 | +100.0% | 2.00% | – |
| PHR | Sell | PHREESIA INCequity | $9,219,000 | -4.4% | 175,000 | -41.7% | 1.92% | -35.3% |
| OPTN | Buy | OPTINOSE INCequity | $8,411,000 | +16.6% | 1,972,000 | +6.6% | 1.75% | -21.2% |
| VTRS | New | VIATRIS INCequity | $8,384,000 | – | 450,000 | +100.0% | 1.75% | – |
| PLXS | Sell | PLEXUS CORPequity | $7,879,000 | -23.1% | 100,000 | -31.0% | 1.64% | -48.0% |
| IPOB | New | SOCIAL CAPITAL HEDOSOPHIA-Aequity | $7,160,000 | – | 450,000 | +100.0% | 1.49% | – |
| STRM | STREAMLINE HEALTH SOLUTIONSequity | $6,932,000 | +3.2% | 4,305,882 | 0.0% | 1.44% | -30.2% | |
| LMNX | New | LUMINEX CORPequity | $6,045,000 | – | 250,000 | +100.0% | 1.26% | – |
| ITGR | New | INTEGER HOLDINGS CORPequity | $5,842,000 | – | 74,000 | +100.0% | 1.22% | – |
| ISEE | Sell | IVERIC BIO INCequity | $5,814,000 | +14.5% | 850,000 | -5.6% | 1.21% | -22.6% |
| ANGO | New | ANGIODYNAMICS INCequity | $5,557,000 | – | 360,000 | +100.0% | 1.16% | – |
| PLNT | New | PLANET FITNESS INC - CL Aequity | $5,547,000 | – | 75,000 | +100.0% | 1.16% | – |
| EW | EDWARDS LIFESCIENCES CORPequity | $4,424,000 | +10.8% | 50,000 | 0.0% | 0.92% | -25.0% | |
| New | GLD US 09/17/21 C200call | $4,200,000 | – | 6,000 | +100.0% | 0.88% | – | |
| INMD | New | INMODE LTDequity | $4,145,000 | – | 90,000 | +100.0% | 0.86% | – |
| MSON | MISONIX INCequity | $3,762,000 | +6.9% | 300,000 | 0.0% | 0.78% | -27.7% | |
| TRHC | New | TABULA RASA HEALTHCARE INCequity | $3,344,000 | – | 80,000 | +100.0% | 0.70% | – |
| CLVR | New | CLEVER LEAVES HOLDINGS INCequity | $2,643,000 | – | 300,000 | +100.0% | 0.55% | – |
| New | IWO US 01/15/21 P280put | $1,920,000 | – | 3,000 | +100.0% | 0.40% | – | |
| New | VTRS US 01/15/21 C15call | $1,875,000 | – | 5,000 | +100.0% | 0.39% | – | |
| MRVI | New | MARAVAI LIFESCIENCES HLDGS-Aequity | $1,372,000 | – | 50,000 | +100.0% | 0.29% | – |
| SRSA | New | SARISSA CAPITAL ACQUISITIONequity unit | $1,346,000 | – | 125,000 | +100.0% | 0.28% | – |
| New | DERMTECH INCequity | $798,000 | – | 25,000 | +100.0% | 0.17% | – | |
| New | JNJ US 01/15/21 C160call | $785,000 | – | 4,000 | +100.0% | 0.16% | – | |
| SSPK | New | SILVER SPIKE ACQUISITION-Aequity | $651,000 | – | 50,000 | +100.0% | 0.14% | – |
| New | TLT US 01/15/21 P159put | $500,000 | – | 2,000 | +100.0% | 0.10% | – | |
| New | TNDM US 01/15/21 P85put | $180,000 | – | 1,500 | +100.0% | 0.04% | – | |
| New | PRGO US 01/15/21 C50call | $15,000 | – | 1,500 | +100.0% | 0.00% | – | |
| Exit | TPB US 10/16/20 C30call | $0 | – | -1,000 | -100.0% | -0.02% | – | |
| Exit | MDT US 10/16/20 C105call | $0 | – | -2,000 | -100.0% | -0.10% | – | |
| Exit | NUAN US 12/18/20 C35call | $0 | – | -3,000 | -100.0% | -0.19% | – | |
| MYL | Exit | MYLAN NVequity | $0 | – | -50,000 | -100.0% | -0.23% | – |
| Exit | IBB US 10/16/20 P140put | $0 | – | -2,000 | -100.0% | -0.23% | – | |
| Exit | IWM US 11/20/20 P150put | $0 | – | -2,000 | -100.0% | -0.46% | – | |
| ALGN | Exit | ALIGN TECHNOLOGY INCequity | $0 | – | -5,000 | -100.0% | -0.50% | – |
| QDEL | Exit | QUIDEL CORPequity | $0 | – | -10,000 | -100.0% | -0.68% | – |
| Exit | GLD US 09/17/21 C200call | $0 | – | -3,000 | -100.0% | -0.73% | – | |
| PDCO | Exit | PATTERSON COS INCequity | $0 | – | -100,000 | -100.0% | -0.74% | – |
| AHCO | Exit | ADAPTHEALTH CORPequity | $0 | – | -305,000 | -100.0% | -2.05% | – |
| BIO | Exit | BIO-RAD LABORATORIES-Aequity | $0 | – | -15,000 | -100.0% | -2.38% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-10
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERADIGM ORD | 32 | Q3 2023 | 13.9% |
| STREAMLINE HEALTH SOLUTIONS ORD | 30 | Q3 2023 | 4.0% |
| ATRICURE ORD | 29 | Q3 2023 | 7.6% |
| PACIRA PHARMACEUTICALS INC | 27 | Q1 2023 | 12.1% |
| LANTHEUS HOLDINGS ORD | 25 | Q4 2022 | 9.6% |
| MEDTRONIC PLC | 21 | Q1 2022 | 12.7% |
| RIGEL PHARMACEUTICALS ORD | 21 | Q2 2023 | 8.0% |
| BIO RAD LABORATORIES CL A ORD | 19 | Q2 2023 | 10.0% |
| HOLOGIC INC | 17 | Q1 2022 | 6.5% |
| SPY US 10/21/16 P210 | 17 | Q3 2023 | 41.5% |
View Tamarack Advisers, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| STREAMLINE HEALTH SOLUTIONS INC. | June 22, 2023 | 5,514,515 | 9.4% |
| IVERIC bio, Inc. | February 16, 2021 | 850,000 | 0.1% |
| Correvio Pharma Corp. | February 14, 2020 | 2,500,000 | 4.9% |
| OBALON THERAPEUTICS INC | February 14, 2020 | ? | ? |
| Correvio Pharma Corp. | February 15, 2019 | ? | ? |
| Corium International, Inc. | February 15, 2017 | 737,242 | 3.3% |
| ENDOLOGIX INC /DE/Sold out | February 15, 2017 | 0 | 0.0% |
| Imprivata IncSold out | February 15, 2017 | 0 | 0.0% |
View Tamarack Advisers, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-16 |
| 13F-HR | 2023-08-10 |
| SC 13D/A | 2023-06-22 |
| 13F-HR | 2023-05-11 |
| 13F-HR | 2023-02-13 |
| SC 13D/A | 2022-12-01 |
| 13F-HR | 2022-11-15 |
| 13F-HR | 2022-08-16 |
| 13F-HR | 2022-05-11 |
View Tamarack Advisers, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.